4.5 Article

Deep ulcers are associated with increased C-reactive protein in active ulcerative colitis

期刊

DIGESTIVE AND LIVER DISEASE
卷 55, 期 9, 页码 1194-1200

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.dld.2023.05.004

关键词

Ulcerative colitis; Acute severe ulcerative colitis; Severe endoscopic lesions; Deep ulcers; UCEIS; C-reactive protein; Albumin; Endoscopy

向作者/读者索取更多资源

This study aimed to investigate the connection between CRP elevation and deep ulcers in UC. The results showed that patients with CRP > 100 mg/L had a higher likelihood of having deep ulcers, which may influence the choice of treatment for acute severe UC.
Background: Increased C-reactive protein (CRP) is used to diagnose and predict response to treatment in acute severe ulcerative colitis (UC). Aims: To investigate the connection between CRP elevation and deep ulcers in UC. Methods: Patients with active UC were enrolled in a multicenter prospective cohort and a retrospective cohort of consecutive patients undergoing colectomy from 2012 to 2019. Results: Forty-one (9 (22%) with deep ulcers) patients were included in the prospective cohort: 4/5 (80%) patients with CRP > 100 mg/L, 2/10 (20%) patients with CRP between 30 and 100 mg/L and 3/26 (12%) patients with CRP < 30 mg/L had deep ulcers (p = 0.006). In the retrospective cohort [46 patients (31 (67%) with deep ulcers)], 14/14 (100%) patients with CRP > 100 mg/L, 11/17 (65%) patients with CRP between 30 and 100 mg/l and 6/15 (40%) patients with CRP < 30 mg/L had deep ulcers (p = 0.001). Positive predictive value of CRP > 100 mg/l for presence of deep ulcers was 80% and 100% in both cohorts, respectively. Conclusions: CRP elevation is a robust surrogate marker for presence of deep ulcers in UC. Elevated CRP or presence of deep ulcers could influence the choice of medical therapy in acute severe UC. (c) 2023 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据